{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:07:52Z","timestamp":1773414472922,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04608-x","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T05:36:18Z","timestamp":1770615378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility of an oral hydration regimen post high-dose methotrexate in children with acute leukemia: a pilot study"],"prefix":"10.1007","volume":"17","author":[{"given":"Padma Sagarika","family":"Karri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruksana","family":"Sidhique PR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish Prasad","family":"Meena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachna","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"12","key":"4608_CR1","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","volume":"21","author":"SC Howard","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of High-Dose methotrexate. Oncologist. 2016;21(12):1471\u201382.","journal-title":"Oncologist"},{"issue":"12","key":"4608_CR2","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/JCO.1987.5.12.2017","volume":"5","author":"SP Ackland","year":"1987","unstructured":"Ackland SP, Schilsky RL. High-dose methotrexate: a critical reappraisal. J Clin Oncol. 1987;5(12):2017\u201331.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4608_CR3","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/clinchem\/42.8.1322","volume":"42","author":"SP Treon","year":"1996","unstructured":"Treon SP, Chabner BA. Concepts in use of high-dose methotrexate therapy. Clin Chem. 1996;42(8):1322\u20139.","journal-title":"Clin Chem"},{"key":"4608_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.annemergmed.2008.11.024","volume":"53","author":"DF Hillier","year":"2009","unstructured":"Hillier DF, Parry GJ, Shannon MW, et al. The effect of hospital bed occupancy on throughput in the pediatric emergency department. Ann Emerg Med. 2009;53:767\u201376.","journal-title":"Ann Emerg Med"},{"key":"4608_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.annemergmed.2009.02.001","volume":"54","author":"SW Liu","year":"2009","unstructured":"Liu SW, Thomas SH, Gordon JA, et al. A pilot study examining undesirable events among emergency department- boarded patients awaiting inpatient beds. Ann Emerg Med. 2009;54:381\u20135.","journal-title":"Ann Emerg Med"},{"key":"4608_CR6","unstructured":"Spranklin L, Agostino N. Decreasing length of stay in patients receiving high dose methotrexate A quality improvement Project. Poster presented at: LVHN department of medicine research Day; 2016, April 26. Lehigh Valley Health Network, Allentown, PA."},{"issue":"Supplement 1","key":"4608_CR7","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1182\/blood-2022-167791","volume":"140","author":"W Toama","year":"2022","unstructured":"Toama W, Kolla B, Hoiness J, Hurley P, Dudek A, Gustafson S, Jahagirdar B. Safety of novel inpatient high dose methotrexate protocol with reduced length of hospital stay. Blood. 2022;140(Supplement 1):5079\u201380.","journal-title":"Blood"},{"key":"4608_CR8","doi-asserted-by":"publisher","first-page":"773397","DOI":"10.3389\/fonc.2021.773397","volume":"11","author":"K Sokol","year":"2022","unstructured":"Sokol K, Yuan K, Piddoubny M, Sweeney E, Delengowski A, Fendler K. et. al. Implementation of an outpatient HD-MTX initiative. Front Oncol. 2022;11:773397.","journal-title":"Front Oncol"},{"issue":"28suppl","key":"4608_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1200\/JCO.2020.39.28_suppl.34","volume":"39","author":"B Genge","year":"2021","unstructured":"Genge B, Carasco T, Young L, Laporte L, Baetz TD. Can high-dose methotrexate be safely administered to outpatients? J Clin Oncol. 2021;39(28suppl):34\u201334.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4608_CR10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/pbc.21419","volume":"50","author":"S Zelcer","year":"2008","unstructured":"Zelcer S, Kellick M, Wexler LH, Gorlick R, Meyers PA. The memorial sloan kettering cancer center experience with outpatient administration of high dose methotrexate with leucovorin rescue. Pediatr Blood Cancer. 2008;50(6):1176\u201380.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"4608_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/pbc.22772","volume":"55","author":"KM Mahadeo","year":"2010","unstructured":"Mahadeo KM, Santizo R, Baker L, Curry JO, Gorlick R, Levy AS. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective: ambulatory High-Dose methotrexate. Pediatr Blood Cancer. 2010;55(7):1296\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"4608_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/MPH.0000000000001238","volume":"41","author":"E Hendershot","year":"2019","unstructured":"Hendershot E, Volpe J, Taylor T, Nicksy D, Mills D, Ramachandran N, Shaikh F, Riss V, Grant R, Gupta AA. Outpatient High-dose methotrexate for osteosarcoma: it\u2019s safe and Feasible, if you want it. J Pediatr Hematol Oncol. 2019;41(5):394\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"4608_CR13","first-page":"381","volume":"9","author":"JL Bartholomew","year":"2018","unstructured":"Bartholomew JL, Dai H, August KJ, Ryan RE, Stegenga KA. Feasibility of outpatient High-Dose methotrexate infusions in pediatric patients with B-Lineage acute lymphoblastic leukemia. J Adv Pract Oncol. 2018;9(4):381\u20136.","journal-title":"J Adv Pract Oncol"},{"issue":"3","key":"4608_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/1043454220907549","volume":"37","author":"L Ranney","year":"2020","unstructured":"Ranney L, Hooke MC, Robbins K. Letting kids be kids: A quality improvement project to deliver supportive care at home after High-Dose methotrexate in pediatric patients with acute lymphoblastic leukemia. J Pediatr Oncol Nurs. 2020;37(3):212\u201320.","journal-title":"J Pediatr Oncol Nurs"},{"issue":"4","key":"4608_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00277-020-04341-7","volume":"100","author":"S Bernard","year":"2021","unstructured":"Bernard S, Hachon L, Diasonama JF, Madaoui C, Aguinaga L, Miekoutima E, Moatti H, Perrial E, Madelaine I, Brice P, Thieblemont C. Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma. Ann Hematol. 2021;100(4):979\u201386.","journal-title":"Ann Hematol"},{"issue":"3","key":"4608_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/1078155219852412","volume":"26","author":"R Pamp\u00edn","year":"2020","unstructured":"Pamp\u00edn R, Labeaga Y, Rodr\u00edguez B, Fern\u00e1ndez B, Fern\u00e1ndez R, Carbajales M. Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma. J Oncol Pharm Pract. 2020;26(3):549\u201355.","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"4608_CR17","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1097\/MPH.0000000000000922","volume":"39","author":"JA Villegas Rubio","year":"2017","unstructured":"Villegas Rubio JA, Cacciavillano W, Rose A, Zubizarreta P, Scopinaro M. Ambulatory High-dose methotrexate administration in pediatric osteosarcoma patients at a single institution in Argentina. J Pediatr Hematol Oncol. 2017;39(7):e349\u201352.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"4608_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.6004\/jadpro.2022.13.2.5","volume":"13","author":"E Armideo","year":"2022","unstructured":"Armideo E, Froio S, Johnson M, Tardino-Gingrich A, Froh E. Evidence-Based criteria supporting early discharge for pediatric patients with osteosarcoma receiving High-Dose methotrexate: A retrospective chart review. J Adv Pract Oncol. 2022;13(2):143\u20139.","journal-title":"J Adv Pract Oncol"},{"issue":"1","key":"4608_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13063-022-06033-1","volume":"23","author":"N Das","year":"2022","unstructured":"Das N, Banavali S, Bakhshi S, Trehan A, Radhakrishnan V, Seth R. Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India. Trials. 2022;23(1):102.","journal-title":"Trials"},{"issue":"1","key":"4608_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s40199-023-00499-3","volume":"32","author":"R Kaveh-Ahangaran","year":"2024","unstructured":"Kaveh-Ahangaran R, Abdollahi M, Vaezi M, Kasaeian A, Bahlouli Z, Janbabaei G. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis. DARU J Pharm Sci. 2024;32(1):353\u201377.","journal-title":"DARU J Pharm Sci"},{"issue":"1","key":"4608_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/1078155220915769","volume":"27","author":"M Diachinsky","year":"2021","unstructured":"Diachinsky M, Tran T, Jupp J, McKinnon K. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience. J Oncol Pharm Pract. 2021;27(1):119\u201327.","journal-title":"J Oncol Pharm Pract"},{"key":"4608_CR22","doi-asserted-by":"publisher","first-page":"i5239","DOI":"10.1136\/bmj.i5239","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L. et. al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239.","journal-title":"BMJ"},{"issue":"6","key":"4608_CR23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3109\/10428194.2013.840780","volume":"55","author":"J May","year":"2014","unstructured":"May J, Carson KR, Butler S, Liu W, Bartlett NL, Wagner-Johnston ND. High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis. Leuk Lymphoma. 2014;55(6):1345\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"4608_CR24","first-page":"e8674","volume":"12","author":"AR Chen","year":"2020","unstructured":"Chen AR, Wang YM, Lin M, Kuo DJ. High-Dose methotrexate in pediatric acute lymphoblastic leukemia: predictors of delayed clearance and the effect of increased hydration rate on methotrexate clearance. Cureus. 2020;12(6):e8674.","journal-title":"Cureus"},{"issue":"Supplement 1","key":"4608_CR25","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1182\/blood-2022-168710","volume":"140","author":"C Egnell Gustafsson","year":"2022","unstructured":"Egnell Gustafsson C, G\u00f6tzsche Frederiksen G, Thorwaldson J, Heyman M, Harila-Saari A, Ranta S. High-Dose Methotrexate-Related toxicity in children with acute lymphoblastic leukemia. Blood. 2022;140(Supplement 1):6033\u20134.","journal-title":"Blood"},{"issue":"12","key":"4608_CR26","doi-asserted-by":"publisher","first-page":"e27241","DOI":"10.1002\/pbc.27241","volume":"65","author":"K Vaishnavi","year":"2018","unstructured":"Vaishnavi K, Bansal D, Trehan A, Jain R, Attri SV. Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin. Pediatr Blood Cancer. 2018;65(12):e27241.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"4608_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/pbc.24081","volume":"59","author":"G Kapoor","year":"2012","unstructured":"Kapoor G, Sinha R, Abedin S. Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country: HDMTX in childhood ALL. Pediatr Blood Cancer. 2012;59(3):448\u201353.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"4608_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s12288-019-01245-z","volume":"36","author":"P Mandal","year":"2020","unstructured":"Mandal P, Samaddar S, Chandra J, Parakh N, Goel M. Adverse effects with intravenous methotrexate in children with acute lymphoblastic leukemia\/lymphoma: a retrospective study. Indian J Hematol Blood Transfus. 2020;36(3):498\u2013504.","journal-title":"Indian J Hematol Blood Transfus"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04608-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04608-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04608-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:25:32Z","timestamp":1773401132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04608-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4608"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04608-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institute Ethics Committee of All India Institute of Medical Sciences, New Delhi (IECPG-542\/23.09.2021, RT-23\/25.11.2021, OT-06\/07.06.2023) on 23.09.2021. The study was registered under Clinical Trials Registry \u2013 India (CTRI\/2022\/02\/040229 dated 11.02.2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All procedures performed in the study were in accordance with the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Accordance"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form (including individual details, images, or videos).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Written informed consent to participate in this study was provided by the participants\u2019 legal guardian. Assent was also obtained from all minor participants where possible.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"420"}}